4 × 180 k cytosureisca v2 oligonucleotide microarray platform (Oxford Gene Technology)
Structured Review

4 × 180 K Cytosureisca V2 Oligonucleotide Microarray Platform, supplied by Oxford Gene Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+oligonucleotide+platform/4+%C3%97+180+k+cytosureisca+v2+oligonucleotide+microarray+platform/pmc05865210-168-9-14
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray"
Article Title: Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray
Journal: European Journal of Human Genetics
doi: 10.1038/s41431-017-0020-3
Figure Legend Snippet: Number of activities by type prompted by sequential testing scenario: non-diagnostic CMA followed by diagnostic and non-diagnostic WGS results (n = 93). CMA chromosomal microarray analysis, WGS whole genome sequencing. 1. Lab tests may include genetic, biochemical and hematogy tests. Allied health may include audiology, dietetics/nutrition, occupational therapy and physiotherapy, spech and language therapy and psychology. Other activities may include electrocardiogram (ECG) electroencephalogram (EEG), Holter monitor, visual evoked potential (VEP), electromyography (EMG), Electroretinography (ERG), evoked potential, monitoring and surveillance and other. 2. The number of times a given test was implemented was included in the activity count. 3. Activities that are standard after CMA or WGS tests, validation testing (Sanger sequencing) and genetic counselling were not included
Techniques Used: Diagnostic Assay, Microarray, Sequencing, Activity Assay, Biomarker Discovery
Related Articles
Microarray:Article Title: Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray Article Snippet: .. CMA was undertaken using the 4 × 180 K Article Title: Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray Article Snippet: .. Platforms CMA was undertaken using the 4 × 180 K Diagnostic Assay:Article Title: Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray Article Snippet: .. CMA was undertaken using the 4 × 180 K Article Title: Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray Article Snippet: .. Platforms CMA was undertaken using the 4 × 180 K |


